nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—NR3C1—polycystic ovary syndrome	0.87	1	CbGaD
Budesonide—Viral diarrhoea—Metformin—polycystic ovary syndrome	0.00881	0.111	CcSEcCtD
Budesonide—Appetite absent—Metformin—polycystic ovary syndrome	0.00462	0.058	CcSEcCtD
Budesonide—Contusion—Metformin—polycystic ovary syndrome	0.00264	0.0331	CcSEcCtD
Budesonide—NR3C1—urine—polycystic ovary syndrome	0.00246	0.246	CbGeAlD
Budesonide—Lightheadedness—Metformin—polycystic ovary syndrome	0.00206	0.0258	CcSEcCtD
Budesonide—Ear pain—Metformin—polycystic ovary syndrome	0.00196	0.0246	CcSEcCtD
Budesonide—CYP3A4—urine—polycystic ovary syndrome	0.00186	0.186	CbGeAlD
Budesonide—Nasal congestion—Metformin—polycystic ovary syndrome	0.00183	0.023	CcSEcCtD
Budesonide—Migraine—Metformin—polycystic ovary syndrome	0.00164	0.0206	CcSEcCtD
Budesonide—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00152	0.0191	CcSEcCtD
Budesonide—Breast disorder—Metformin—polycystic ovary syndrome	0.00151	0.0189	CcSEcCtD
Budesonide—Cramp muscle—Metformin—polycystic ovary syndrome	0.0015	0.0189	CcSEcCtD
Budesonide—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00149	0.0187	CcSEcCtD
Budesonide—Abdominal distension—Metformin—polycystic ovary syndrome	0.00145	0.0182	CcSEcCtD
Budesonide—Influenza—Metformin—polycystic ovary syndrome	0.00144	0.0181	CcSEcCtD
Budesonide—Sweating increased—Metformin—polycystic ovary syndrome	0.00141	0.0176	CcSEcCtD
Budesonide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.00139	0.048	CbGpPWpGaD
Budesonide—Infestation NOS—Metformin—polycystic ovary syndrome	0.00129	0.0162	CcSEcCtD
Budesonide—Infestation—Metformin—polycystic ovary syndrome	0.00129	0.0162	CcSEcCtD
Budesonide—Rhinitis—Metformin—polycystic ovary syndrome	0.00116	0.0145	CcSEcCtD
Budesonide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00114	0.0143	CcSEcCtD
Budesonide—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00113	0.0142	CcSEcCtD
Budesonide—Eye disorder—Metformin—polycystic ovary syndrome	0.00108	0.0136	CcSEcCtD
Budesonide—Flushing—Metformin—polycystic ovary syndrome	0.00107	0.0135	CcSEcCtD
Budesonide—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00107	0.0135	CcSEcCtD
Budesonide—Angiopathy—Metformin—polycystic ovary syndrome	0.00105	0.0132	CcSEcCtD
Budesonide—Immune system disorder—Metformin—polycystic ovary syndrome	0.00104	0.0131	CcSEcCtD
Budesonide—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00104	0.0131	CcSEcCtD
Budesonide—Malnutrition—Metformin—polycystic ovary syndrome	0.00101	0.0126	CcSEcCtD
Budesonide—Flatulence—Metformin—polycystic ovary syndrome	0.00099	0.0124	CcSEcCtD
Budesonide—Dysgeusia—Metformin—polycystic ovary syndrome	0.000984	0.0124	CcSEcCtD
Budesonide—Muscle spasms—Metformin—polycystic ovary syndrome	0.000966	0.0121	CcSEcCtD
Budesonide—Vision blurred—Metformin—polycystic ovary syndrome	0.000947	0.0119	CcSEcCtD
Budesonide—Tremor—Metformin—polycystic ovary syndrome	0.000942	0.0118	CcSEcCtD
Budesonide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000932	0.0117	CcSEcCtD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—INSR—polycystic ovary syndrome	0.000928	0.032	CbGpPWpGaD
Budesonide—Malaise—Metformin—polycystic ovary syndrome	0.000906	0.0114	CcSEcCtD
Budesonide—Syncope—Metformin—polycystic ovary syndrome	0.000901	0.0113	CcSEcCtD
Budesonide—Palpitations—Metformin—polycystic ovary syndrome	0.000888	0.0112	CcSEcCtD
Budesonide—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000883	0.0111	CcSEcCtD
Budesonide—Hypertension—Metformin—polycystic ovary syndrome	0.000868	0.0109	CcSEcCtD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—polycystic ovary syndrome	0.000857	0.0295	CbGpPWpGaD
Budesonide—Myalgia—Metformin—polycystic ovary syndrome	0.000856	0.0107	CcSEcCtD
Budesonide—Chest pain—Metformin—polycystic ovary syndrome	0.000856	0.0107	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00085	0.0107	CcSEcCtD
Budesonide—Discomfort—Metformin—polycystic ovary syndrome	0.000845	0.0106	CcSEcCtD
Budesonide—Infection—Metformin—polycystic ovary syndrome	0.000815	0.0102	CcSEcCtD
Budesonide—Shock—Metformin—polycystic ovary syndrome	0.000807	0.0101	CcSEcCtD
Budesonide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000804	0.0101	CcSEcCtD
Budesonide—Skin disorder—Metformin—polycystic ovary syndrome	0.000797	0.01	CcSEcCtD
Budesonide—NR3C1—embryo—polycystic ovary syndrome	0.000796	0.0796	CbGeAlD
Budesonide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000793	0.00996	CcSEcCtD
Budesonide—Anorexia—Metformin—polycystic ovary syndrome	0.000782	0.00982	CcSEcCtD
Budesonide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.000775	0.0267	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000774	0.0267	CbGpPWpGaD
Budesonide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000747	0.00939	CcSEcCtD
Budesonide—Paraesthesia—Metformin—polycystic ovary syndrome	0.000737	0.00925	CcSEcCtD
Budesonide—Dyspnoea—Metformin—polycystic ovary syndrome	0.000731	0.00918	CcSEcCtD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—polycystic ovary syndrome	0.000731	0.0252	CbGpPWpGaD
Budesonide—Somnolence—Metformin—polycystic ovary syndrome	0.000729	0.00916	CcSEcCtD
Budesonide—Dyspepsia—Metformin—polycystic ovary syndrome	0.000722	0.00907	CcSEcCtD
Budesonide—Decreased appetite—Metformin—polycystic ovary syndrome	0.000713	0.00896	CcSEcCtD
Budesonide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000708	0.00889	CcSEcCtD
Budesonide—Fatigue—Metformin—polycystic ovary syndrome	0.000707	0.00888	CcSEcCtD
Budesonide—Constipation—Metformin—polycystic ovary syndrome	0.000701	0.00881	CcSEcCtD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—polycystic ovary syndrome	0.00069	0.0238	CbGpPWpGaD
Budesonide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000676	0.00849	CcSEcCtD
Budesonide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000671	0.00842	CcSEcCtD
Budesonide—NR3C1—adrenal cortex—polycystic ovary syndrome	0.000653	0.0652	CbGeAlD
Budesonide—Urticaria—Metformin—polycystic ovary syndrome	0.000652	0.00818	CcSEcCtD
Budesonide—Abdominal pain—Metformin—polycystic ovary syndrome	0.000648	0.00814	CcSEcCtD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—polycystic ovary syndrome	0.000624	0.0215	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.000621	0.0214	CbGpPWpGaD
Budesonide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.000597	0.0206	CbGpPWpGaD
Budesonide—Asthenia—Metformin—polycystic ovary syndrome	0.000588	0.00739	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—LIFR—polycystic ovary syndrome	0.000585	0.0202	CbGpPWpGaD
Budesonide—NR3C1—endometrium—polycystic ovary syndrome	0.000583	0.0582	CbGeAlD
Budesonide—Testolactone—CYP19A1—polycystic ovary syndrome	0.000582	0.0531	CrCbGaD
Budesonide—Pruritus—Metformin—polycystic ovary syndrome	0.00058	0.00729	CcSEcCtD
Budesonide—Diarrhoea—Metformin—polycystic ovary syndrome	0.000561	0.00705	CcSEcCtD
Budesonide—NR3C1—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000555	0.0191	CbGpPWpGaD
Budesonide—Dizziness—Metformin—polycystic ovary syndrome	0.000542	0.00681	CcSEcCtD
Budesonide—NR3C1—uterus—polycystic ovary syndrome	0.000537	0.0536	CbGeAlD
Budesonide—NR3C1—pituitary gland—polycystic ovary syndrome	0.000527	0.0527	CbGeAlD
Budesonide—NR3C1—adipose tissue—polycystic ovary syndrome	0.000525	0.0525	CbGeAlD
Budesonide—Vomiting—Metformin—polycystic ovary syndrome	0.000522	0.00655	CcSEcCtD
Budesonide—Rash—Metformin—polycystic ovary syndrome	0.000517	0.0065	CcSEcCtD
Budesonide—Dermatitis—Metformin—polycystic ovary syndrome	0.000517	0.00649	CcSEcCtD
Budesonide—Headache—Metformin—polycystic ovary syndrome	0.000514	0.00645	CcSEcCtD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.000494	0.017	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IRS2—polycystic ovary syndrome	0.000491	0.0169	CbGpPWpGaD
Budesonide—Nausea—Metformin—polycystic ovary syndrome	0.000487	0.00612	CcSEcCtD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—polycystic ovary syndrome	0.000481	0.0166	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—LIF—polycystic ovary syndrome	0.000477	0.0164	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—RETN—polycystic ovary syndrome	0.000477	0.0164	CbGpPWpGaD
Budesonide—Prednicarbate—NR3C1—polycystic ovary syndrome	0.000471	0.043	CrCbGaD
Budesonide—Clocortolone—NR3C1—polycystic ovary syndrome	0.000471	0.043	CrCbGaD
Budesonide—NR3C1—adrenal gland—polycystic ovary syndrome	0.000471	0.0471	CbGeAlD
Budesonide—NR3C1—Circadian Clock—NAMPT—polycystic ovary syndrome	0.000454	0.0157	CbGpPWpGaD
Budesonide—Desonide—NR3C1—polycystic ovary syndrome	0.000446	0.0407	CrCbGaD
Budesonide—Diflorasone—NR3C1—polycystic ovary syndrome	0.000446	0.0407	CrCbGaD
Budesonide—NR3C1—female gonad—polycystic ovary syndrome	0.000439	0.0439	CbGeAlD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000439	0.0151	CbGpPWpGaD
Budesonide—NR3C1—vagina—polycystic ovary syndrome	0.000437	0.0436	CbGeAlD
Budesonide—Desoximetasone—NR3C1—polycystic ovary syndrome	0.000435	0.0397	CrCbGaD
Budesonide—NR3C1—Nuclear Receptors—AR—polycystic ovary syndrome	0.000432	0.0149	CbGpPWpGaD
Budesonide—Loteprednol—NR3C1—polycystic ovary syndrome	0.00043	0.0392	CrCbGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000429	0.0148	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IRS1—polycystic ovary syndrome	0.000429	0.0148	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—polycystic ovary syndrome	0.000419	0.0144	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.000417	0.0144	CbGpPWpGaD
Budesonide—NR3C1—endocrine gland—polycystic ovary syndrome	0.000409	0.0408	CbGeAlD
Budesonide—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.000392	0.0135	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—polycystic ovary syndrome	0.000385	0.0133	CbGpPWpGaD
Budesonide—Flurandrenolide—NR3C1—polycystic ovary syndrome	0.000381	0.0347	CrCbGaD
Budesonide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.000375	0.0129	CbGpPWpGaD
Budesonide—Hydrocortamate—NR3C1—polycystic ovary syndrome	0.000368	0.0336	CrCbGaD
Budesonide—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000362	0.0125	CbGpPWpGaD
Budesonide—Amcinonide—NR3C1—polycystic ovary syndrome	0.000342	0.0312	CrCbGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.000341	0.0118	CbGpPWpGaD
Budesonide—Betamethasone—PGR—polycystic ovary syndrome	0.000333	0.0303	CrCbGaD
Budesonide—NR3C1—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000331	0.0114	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000331	0.0114	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—AR—polycystic ovary syndrome	0.000331	0.0114	CbGpPWpGaD
Budesonide—Mometasone—NR3C1—polycystic ovary syndrome	0.000326	0.0297	CrCbGaD
Budesonide—Rimexolone—NR3C1—polycystic ovary syndrome	0.000322	0.0294	CrCbGaD
Budesonide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000309	0.0309	CbGeAlD
Budesonide—Beclomethasone—NR3C1—polycystic ovary syndrome	0.000304	0.0277	CrCbGaD
Budesonide—Fluocinonide—NR3C1—polycystic ovary syndrome	0.000304	0.0277	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—TH—polycystic ovary syndrome	0.000298	0.0103	CbGpPWpGaD
Budesonide—Fluocinolone Acetonide—NR3C1—polycystic ovary syndrome	0.000295	0.0269	CrCbGaD
Budesonide—Alclometasone—NR3C1—polycystic ovary syndrome	0.000295	0.0269	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	0.000294	0.0102	CbGpPWpGaD
Budesonide—Clobetasol propionate—NR3C1—polycystic ovary syndrome	0.000287	0.0262	CrCbGaD
Budesonide—Flunisolide—NR3C1—polycystic ovary syndrome	0.000287	0.0262	CrCbGaD
Budesonide—Paramethasone—NR3C1—polycystic ovary syndrome	0.000284	0.0259	CrCbGaD
Budesonide—NR3C1—Circadian Clock—NCOR1—polycystic ovary syndrome	0.000281	0.00968	CbGpPWpGaD
Budesonide—Ciclesonide—NR3C1—polycystic ovary syndrome	0.000279	0.0255	CrCbGaD
Budesonide—Fluorometholone—NR3C1—polycystic ovary syndrome	0.000277	0.0253	CrCbGaD
Budesonide—NR3C1—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.00027	0.00932	CbGpPWpGaD
Budesonide—Methylprednisolone—NR3C1—polycystic ovary syndrome	0.000268	0.0244	CrCbGaD
Budesonide—Clobetasol propionate—CYP1A1—polycystic ovary syndrome	0.000261	0.0238	CrCbGaD
Budesonide—Dexamethasone—CYP17A1—polycystic ovary syndrome	0.000261	0.0238	CrCbGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000259	0.00891	CbGpPWpGaD
Budesonide—Dexamethasone—CYP11A1—polycystic ovary syndrome	0.000257	0.0234	CrCbGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—polycystic ovary syndrome	0.000249	0.00858	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000247	0.00851	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—PRL—polycystic ovary syndrome	0.000243	0.00839	CbGpPWpGaD
Budesonide—Hydrocortisone—SHBG—polycystic ovary syndrome	0.000243	0.0221	CrCbGaD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000237	0.00815	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.000236	0.00813	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—polycystic ovary syndrome	0.000236	0.00812	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—NAMPT—polycystic ovary syndrome	0.000228	0.00787	CbGpPWpGaD
Budesonide—Betamethasone—CYP19A1—polycystic ovary syndrome	0.000228	0.0208	CrCbGaD
Budesonide—Triamcinolone—NR3C1—polycystic ovary syndrome	0.000226	0.0206	CrCbGaD
Budesonide—NR3C1—Adipogenesis—LMNA—polycystic ovary syndrome	0.000216	0.00746	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000215	0.00742	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000214	0.00737	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000206	0.0071	CbGpPWpGaD
Budesonide—Prednisone—NR3C1—polycystic ovary syndrome	0.000205	0.0187	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—BAX—polycystic ovary syndrome	0.000199	0.00685	CbGpPWpGaD
Budesonide—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000198	0.00682	CbGpPWpGaD
Budesonide—Dexamethasone—PGR—polycystic ovary syndrome	0.000194	0.0177	CrCbGaD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00019	0.00656	CbGpPWpGaD
Budesonide—Prednisolone—NR3C1—polycystic ovary syndrome	0.000189	0.0172	CrCbGaD
Budesonide—NR3C1—Adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000187	0.00644	CbGpPWpGaD
Budesonide—Betamethasone—NR3C1—polycystic ovary syndrome	0.000185	0.0169	CrCbGaD
Budesonide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000183	0.0063	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000182	0.00626	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—SERPINE1—polycystic ovary syndrome	0.000181	0.00625	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—polycystic ovary syndrome	0.000179	0.00619	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SLC2A4—polycystic ovary syndrome	0.000176	0.00608	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ZNF205—polycystic ovary syndrome	0.00016	0.0055	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ZNF430—polycystic ovary syndrome	0.00016	0.0055	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000157	0.0054	CbGpPWpGaD
Budesonide—Hydrocortisone—NR3C1—polycystic ovary syndrome	0.000144	0.0132	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—polycystic ovary syndrome	0.000144	0.00497	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—NCOR1—polycystic ovary syndrome	0.000141	0.00486	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000139	0.00481	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000139	0.00478	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000137	0.00471	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ADARB1—polycystic ovary syndrome	0.000136	0.00468	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000133	0.00458	CbGpPWpGaD
Budesonide—Dexamethasone—CYP19A1—polycystic ovary syndrome	0.000133	0.0121	CrCbGaD
Budesonide—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00013	0.00447	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000129	0.00444	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000127	0.00438	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000126	0.00435	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IRS2—polycystic ovary syndrome	0.000119	0.00409	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—LEP—polycystic ovary syndrome	0.000116	0.004	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000112	0.00387	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—LSM5—polycystic ovary syndrome	0.000111	0.00381	CbGpPWpGaD
Budesonide—Dexamethasone—NR3C1—polycystic ovary syndrome	0.000108	0.00981	CrCbGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000104	0.0036	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IRS1—polycystic ovary syndrome	0.000104	0.00357	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SAP30L—polycystic ovary syndrome	0.000103	0.00354	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000102	0.00351	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000102	0.0035	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—PPARG—polycystic ovary syndrome	0.000101	0.00348	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000101	0.00347	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—INS—polycystic ovary syndrome	9.91e-05	0.00342	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	9.78e-05	0.00337	CbGpPWpGaD
Budesonide—Dexamethasone—CYP1A1—polycystic ovary syndrome	9.77e-05	0.00891	CrCbGaD
Budesonide—NR3C1—Adipogenesis—IGF1—polycystic ovary syndrome	9.59e-05	0.00331	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SERPINE1—polycystic ovary syndrome	9.11e-05	0.00314	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—TEAD2—polycystic ovary syndrome	8.74e-05	0.00301	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	8.68e-05	0.00299	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	8.26e-05	0.00285	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	8.22e-05	0.00283	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	8.11e-05	0.00279	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	7.58e-05	0.00261	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	7.22e-05	0.00249	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	7.11e-05	0.00245	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	6.73e-05	0.00232	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	6.66e-05	0.0023	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	6.64e-05	0.00229	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	6.26e-05	0.00216	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	6.23e-05	0.00215	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	6.13e-05	0.00211	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	5.97e-05	0.00206	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	5.89e-05	0.00203	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	5.88e-05	0.00203	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	5.56e-05	0.00192	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	5.55e-05	0.00191	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	5.47e-05	0.00189	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	5.41e-05	0.00187	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	5.15e-05	0.00178	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	4.97e-05	0.00171	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	4.39e-05	0.00151	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	4.33e-05	0.00149	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	4.33e-05	0.00149	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	4.18e-05	0.00144	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	3.74e-05	0.00129	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	3.69e-05	0.00127	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	3.69e-05	0.00127	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	3.65e-05	0.00126	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.54e-05	0.00122	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.49e-05	0.0012	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	3.33e-05	0.00115	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.11e-05	0.00107	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.85e-05	0.000981	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.85e-05	0.000981	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AR—polycystic ovary syndrome	2.84e-05	0.000978	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.65e-05	0.000912	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.64e-05	0.000909	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	2.48e-05	0.000855	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.25e-05	0.000776	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.25e-05	0.000776	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.89e-05	0.00065	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.79e-05	0.000616	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	1.78e-05	0.000613	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.71e-05	0.000588	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.6e-05	0.000552	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.52e-05	0.000524	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.45e-05	0.0005	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.32e-05	0.000456	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.29e-05	0.000445	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.25e-05	0.000431	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.15e-05	0.000397	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.12e-05	0.000385	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.08e-05	0.000371	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.03e-05	0.000356	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.02e-05	0.000352	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	9.63e-06	0.000332	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	9.48e-06	0.000327	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	8.21e-06	0.000283	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	7.98e-06	0.000275	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	7.51e-06	0.000259	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	6.7e-06	0.000231	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.38e-06	0.00022	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	6.05e-06	0.000209	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5.64e-06	0.000194	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.57e-06	0.000158	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.51e-06	0.000156	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.49e-06	0.000155	CbGpPWpGaD
